News | October 27, 2025
CPHI & PMEC India 2025 to see participation of 2,000+ exhibitors
The event will be attended by 35,000+ industry professionals
The event will be attended by 35,000+ industry professionals
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or desirable
The company’s “greener” initiatives emphasize eco-friendly excipients and energy-efficient manufacturing processes that reduce environmental impact without compromising product quality
The submissions are supported by data from the Phase 3 KEYNOTE-905 trial
The combination is approved for advanced endometrial carcinoma that is pMMR or not MSI-H and has progressed after prior systemic therapy
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
These findings follow positive Phase 3 results presented earlier this year
The new cGMP-compliant HPAPI Laboratory is equipped with state-of-the-art isolators designed to meet Occupational Exposure Band 5 (OEB-5) requirements
Subscribe To Our Newsletter & Stay Updated
